NCT03814915 (DIRECT) is a clinical trial in Type2 Diabetes, sponsored by Lund University.

Who is sponsoring NCT03814915?

NCT03814915 is sponsored by Lund University.

What condition does NCT03814915 study?

NCT03814915 studies Type2 Diabetes.

Is NCT03814915 still recruiting?

NCT03814915 is currently completed. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT03814915: DIRECT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetes Research on Patient Stratification

Completed Last updated 18 January 2020

What this trial tests

trial in Type2 Diabetes in 3,049 participants. Completed in 31 July 2019.

Timeline

15 October 2012

Primary endpoint
31 July 2019

31 July 2019

Quick facts

Lead sponsor	Lund University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	3,049
Start date	15 October 2012
Primary completion	31 July 2019
Estimated completion	31 July 2019

Conditions studied

Type2 Diabetes — all drugs for Type2 Diabetes →

Sponsor

Lund University

Who can join

Adults 35 to 74, any sex, with Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching goal of the IMI DIRECT (Innovative Medicines Initiative Diabetes Research on Patient Stratification) Consortium is the identification of biomarkers that aid therapeutic targeting in prediabetes (Study 1) or early onset type 2 diabetes (Study 2).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts.
Atabaki-Pasdar N, Ohlsson M, Viñuela A, Frau F, et al · · 2020 · cited 65× · PMID 32559194 · DOI 10.1371/journal.pmed.1003149
Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study.
Eriksen R, Perez IG, Posma JM, Haid M, et al · · 2020 · cited 7× · PMID 32763829 · DOI 10.1016/j.ebiom.2020.102932
The dynamics of the gut microbiota in prediabetes during a four-year follow-up among European patients-an IMI-DIRECT prospective study.
Lyu L, Fan Y, Vogt JK, Clos-Garcia M, et al · · 2025 · cited 1× · PMID 40665409 · DOI 10.1186/s13073-025-01508-7

Verify or expand the search:

Other recruiting trials for Type2 Diabetes

Currently open trials in the same condition.

NCT05277558 — Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) · recruiting
NCT05015283 — Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission · NA · recruiting
NCT05006508 — Prevention With the Health and Lifestyle Tool · NA · active not recruiting
NCT04717050 — Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity · NA · active not recruiting
NCT05220917 — Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study · active not recruiting

Other Lund University trials

Trials by the same sponsor.

NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
NCT07425925 — Digital Peer-support-based Anti-HIV Stigma Intervention Among Adolescents Living With HIV in Ethiopia · NA · recruiting
NCT07407842 — UPSIDES - Recovery Through Peer Support · NA · enrolling by invitation
NCT07141108 — Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life · NA · recruiting
NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03814915 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lund University
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing